Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Ovid Therapeutics (OVID) had Return on Equity of -7.15% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.73M |
|
$-15.01M |
|
-- |
|
$0.73M |
|
$16.43M |
|
$-15.70M |
|
$0.69M |
|
$-15.01M |
|
$-15.01M |
|
$-15.01M |
|
$-15.01M |
|
$-15.01M |
|
$-15.01M |
|
$-15.70M |
|
$-15.68M |
|
197.45M |
|
197.45M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$123.62M |
|
$0.20M |
|
$108.36M |
|
$231.97M |
|
$9.98M |
|
$11.23M |
|
$12.10M |
|
$22.08M |
|
$209.89M |
|
$209.89M |
|
$209.89M |
|
184.76M |
|
| Cash Flow Statement Financials | |
$-31.49M |
|
$-80.79M |
|
$110.58M |
|
$15.08M |
|
$13.26M |
|
$-1.83M |
|
$2.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.39 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
100.00% |
|
-2141.61% |
|
-2141.61% |
|
-- |
|
-2047.61% |
|
-2047.61% |
|
$-31.49M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-7.15% |
-7.15% |
|
-6.47% |
|
-6.79% |
|
$1.14 |
|
$-0.16 |
|
$-0.16 |
|